Dong-A Socio Holdings Co., Ltd. (KRX:000640)
110,100
-100 (-0.09%)
Last updated: Nov 25, 2025, 12:24 PM KST
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 382.60B KRW in the quarter ending September 30, 2025, with 7.20% growth. This brings the company's revenue in the last twelve months to 1.40T, up 9.02% year-over-year. In the year 2024, Dong-A Socio Holdings had annual revenue of 1.33T with 17.78% growth.
Revenue (ttm)
1.40T
Revenue Growth
+9.02%
P/S Ratio
0.52
Revenue / Employee
16.93B
Employees
83
Market Cap
728.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.33T | 201.23B | 17.78% |
| Dec 31, 2023 | 1.13T | 117.14B | 11.54% |
| Dec 31, 2022 | 1.01T | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.50T |
| Celltrion | 3.90T |
| Yuhan | 2.14T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 675.41B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |